vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · IEX Real-Time Price · USD
20.40
-1.00 (-4.67%)
Jul 19, 2024, 4:00 PM EDT - Market closed

vTv Therapeutics Revenue

vTv Therapeutics had revenue of $1.00M in the twelve months ending March 31, 2024, with 5,455.56% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.00M.

Revenue (ttm)
$1.00M
Revenue Growth
+5,455.56%
P/S Ratio
49.63
Revenue / Employee
$62,500
Employees
16
Market Cap
49.63M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 20222.02M-1.99M-49.61%
Dec 31, 20214.01M-2.41M-37.56%
Dec 31, 20206.41M3.65M132.05%
Dec 31, 20192.76M-9.67M-77.77%
Dec 31, 201812.43M12.14M4,172.85%
Dec 31, 2017291.00K-343.00K-54.10%
Dec 31, 2016634.00K115.00K22.16%
Dec 31, 2015519.00K-1.03M-66.49%
Dec 31, 20141.55M573.00K58.71%
Dec 31, 2013976.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inotiv 552.74M
Cidara Therapeutics 46.38M
Bionano Genomics 37.47M
Ocuphire Pharma 19.01M
DURECT 8.32M
Revenue Rankings